首页 > 最新文献

Advances in ophthalmology practice and research最新文献

英文 中文
Global incidence and trends of ocular cancer: A bibliometric analysis 眼癌的全球发病率和趋势:文献计量学分析。
Pub Date : 2025-02-01 DOI: 10.1016/j.aopr.2024.10.004
Hang Xu , Alexander C. Rokohl , Xiaojun Ju , Yongwei Guo , Xincen Hou , Wanlin Fan , Ludwig M. Heindl

Background

Ocular cancer represents a significant threat to vision and life among various eye diseases. Conjunctival melanoma is regarded as one of the most feared and unpredictable ocular tumors. Considering the global differences in the occurrence of ocular melanoma across different races and regions, this study provides a thorough examination of the current state of research pertaining to the epidemiology of ocular and conjunctival cancers.

Methods

This bibliometrics analysis used the Web of Science Core Collection (WoSCC) to collect data from publications on the epidemiology of ocular cancer, including relevant literature from 1951 to 2024. We examined indicators including t publication counts, citation rates, and data on contributing countries, institutions, and journals. Use VOSviewer and CiteSpace for network visualization and Microsoft Excel for data management. Our analysis reveals key trends in the epidemiology of ocular cancer across countries and identifies prominent keywords.

Results

A total of 406 articles on ocular cancer were identified, with significant contributions from the United States, the United Kingdom, and Germany. Denmark also plays a crucial role, particularly in conjunctival cancer research. Carol L. Shields is a leading figure widely recognized for her influential citations in ocular cancer epidemiology. The top publication platforms include the British Journal of Ophthalmology, Ophthalmic Epidemiology, and Ophthalmology. Key terms in ocular cancer research focus on prevalence, survival, and epidemiology, while conjunctival cancer studies emphasize malignant melanoma, conjunctiva, and epidemiology. Through keyword co-occurrence and burst analysis, trending topics include prevalence, risk factors, uveal melanoma, choroidal melanoma, malignant melanoma, squamous cell carcinoma, and conjunctiva. For conjunctival cancer, key research areas expected to remain prominent are cell carcinoma, management, recurrence, ocular surface squamous neoplasia, and pathology.

Conclusions

This analysis represents the first comprehensive bibliometric review mapping the trends and the knowledge structure in ocular cancer research, specifically from an epidemiological viewpoint. The results meticulously explore and encapsulate the research frontiers for scholars dedicated to the epidemiology of conjunctival cancer.
背景:眼癌是各种眼病中对视力和生命构成重大威胁的疾病。结膜黑色素瘤被认为是最令人恐惧和难以预测的眼部肿瘤之一。考虑到全球不同种族和地区眼部黑色素瘤发生的差异,本研究提供了有关眼部和结膜癌流行病学研究现状的全面检查。方法:文献计量学分析采用Web of Science Core Collection (WoSCC)数据库,收集1951 - 2024年眼部肿瘤流行病学相关文献资料。我们检查的指标包括出版物数量、引用率以及贡献国家、机构和期刊的数据。使用VOSviewer和CiteSpace进行网络可视化,使用Microsoft Excel进行数据管理。我们的分析揭示了各国眼癌流行病学的主要趋势,并确定了突出的关键词。结果:共确定了406篇关于眼癌的文章,其中来自美国、英国和德国的贡献很大。丹麦也发挥着至关重要的作用,特别是在结膜癌研究方面。卡罗尔·l·希尔兹是一位领军人物,因其在眼癌流行病学方面的有影响力的引用而得到广泛认可。顶级出版平台包括《英国眼科杂志》、《眼科流行病学》和《眼科学》。眼癌研究的关键术语集中于患病率、生存率和流行病学,而结膜癌研究强调恶性黑色素瘤、结膜和流行病学。通过关键词共现和突发分析,趋势话题包括患病率、危险因素、葡萄膜黑色素瘤、脉络膜黑色素瘤、恶性黑色素瘤、鳞状细胞癌、结膜。结膜癌的重点研究领域是细胞癌、治疗、复发、眼表鳞状瘤变和病理学。结论:这一分析是第一次全面的文献计量学综述,从流行病学的角度,绘制了眼癌研究的趋势和知识结构。研究结果为致力于结膜癌流行病学的学者精心探索和概括了研究前沿。
{"title":"Global incidence and trends of ocular cancer: A bibliometric analysis","authors":"Hang Xu ,&nbsp;Alexander C. Rokohl ,&nbsp;Xiaojun Ju ,&nbsp;Yongwei Guo ,&nbsp;Xincen Hou ,&nbsp;Wanlin Fan ,&nbsp;Ludwig M. Heindl","doi":"10.1016/j.aopr.2024.10.004","DOIUrl":"10.1016/j.aopr.2024.10.004","url":null,"abstract":"<div><h3>Background</h3><div>Ocular cancer represents a significant threat to vision and life among various eye diseases. Conjunctival melanoma is regarded as one of the most feared and unpredictable ocular tumors. Considering the global differences in the occurrence of ocular melanoma across different races and regions, this study provides a thorough examination of the current state of research pertaining to the epidemiology of ocular and conjunctival cancers.</div></div><div><h3>Methods</h3><div>This bibliometrics analysis used the Web of Science Core Collection (WoSCC) to collect data from publications on the epidemiology of ocular cancer, including relevant literature from 1951 to 2024. We examined indicators including t publication counts, citation rates, and data on contributing countries, institutions, and journals. Use VOSviewer and CiteSpace for network visualization and Microsoft Excel for data management. Our analysis reveals key trends in the epidemiology of ocular cancer across countries and identifies prominent keywords.</div></div><div><h3>Results</h3><div>A total of 406 articles on ocular cancer were identified, with significant contributions from the United States, the United Kingdom, and Germany. Denmark also plays a crucial role, particularly in conjunctival cancer research. Carol L. Shields is a leading figure widely recognized for her influential citations in ocular cancer epidemiology. The top publication platforms include the <em>British Journal of Ophthalmology</em>, <em>Ophthalmic Epidemiology</em>, and <em>Ophthalmology</em>. Key terms in ocular cancer research focus on prevalence, survival, and epidemiology, while conjunctival cancer studies emphasize malignant melanoma, conjunctiva, and epidemiology. Through keyword co-occurrence and burst analysis, trending topics include prevalence, risk factors, uveal melanoma, choroidal melanoma, malignant melanoma, squamous cell carcinoma, and conjunctiva. For conjunctival cancer, key research areas expected to remain prominent are cell carcinoma, management, recurrence, ocular surface squamous neoplasia, and pathology.</div></div><div><h3>Conclusions</h3><div>This analysis represents the first comprehensive bibliometric review mapping the trends and the knowledge structure in ocular cancer research, specifically from an epidemiological viewpoint. The results meticulously explore and encapsulate the research frontiers for scholars dedicated to the epidemiology of conjunctival cancer.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"5 1","pages":"Pages 22-31"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11787427/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting ocular malignancies using a novel light-activated virus-like drug conjugate 利用一种新型光激活病毒样药物偶联物靶向眼部恶性肿瘤
Pub Date : 2025-02-01 DOI: 10.1016/j.aopr.2024.12.001
Sen Ma , Ruben V. Huis In't Veld , Elisabet de los Pinos , Ferry A. Ossendorp , Martine J. Jager

Background

Targeted therapy is a promising approach to improve the treatment of tumors, including ocular malignancies. Current therapies, such as radiotherapy and surgery, often lead to serious damage to vision or to loss of the eye. New approaches have examined nanoparticles for use as targeted delivery vehicles for drugs. A newly-developed virus-like drug conjugate is a promising nanoparticle with a defined target: the novel virus-like particle-photosensitizer conjugate Belzupacap sarotalocan (Bel-sar, previous name AU-011).

Main text

In this review, we summarize the application of this novel light-activated virus-like particle conjugate in pre-clinical and clinical studies and discuss its potential to treat ocular malignancies, such as uveal melanoma and conjunctival melanoma. We furthermore discuss the combination with immunotherapy and its application on pigmented and non-pigmented tumors as well as its effect on macrophage polarization, which is important to achieve effective results in immunotherapy.

Conclusions

Belzupacap sarotalocan (Bel-sar) is a promising targeted drug carrier that enhances tumor-specific delivery and minimizes off-target effects. Its photodynamic therapy effectively treats pigmented and non-pigmented tumors while inducing immunogenic cell death through DAMP exposure, triggering local and systemic immune responses. Combining Bel-sar PDT with immunotherapy improves efficacy in preclinical models, warranting further clinical investigation.
背景:靶向治疗是一种很有前途的方法来改善肿瘤的治疗,包括眼恶性肿瘤。目前的治疗方法,如放疗和手术,往往会导致视力严重受损或失明。新的方法研究了纳米颗粒作为药物靶向递送载体的用途。一种新开发的病毒样药物偶联物是一种有前景的纳米颗粒,具有明确的靶标:新型病毒样颗粒-光敏剂偶联物Belzupacap sarotalocan (Bel-sar,原名AU-011)。本文综述了这种新型光激活病毒样颗粒缀合物在临床前和临床研究中的应用,并讨论了其治疗葡萄膜黑色素瘤和结膜黑色素瘤等眼部恶性肿瘤的潜力。我们进一步讨论了与免疫治疗的联合治疗及其在色素肿瘤和非色素肿瘤中的应用,以及对巨噬细胞极化的影响,这对免疫治疗取得有效效果至关重要。结论belzupacap sarotalocan (belzupacap sarotalocan, Bel-sar)是一种很有前途的靶向药物载体,可增强肿瘤特异性递送,减少脱靶效应。其光动力疗法可有效治疗色素和非色素肿瘤,同时通过DAMP暴露诱导免疫原性细胞死亡,引发局部和全身免疫反应。Bel-sar PDT联合免疫治疗提高了临床前模型的疗效,值得进一步的临床研究。
{"title":"Targeting ocular malignancies using a novel light-activated virus-like drug conjugate","authors":"Sen Ma ,&nbsp;Ruben V. Huis In't Veld ,&nbsp;Elisabet de los Pinos ,&nbsp;Ferry A. Ossendorp ,&nbsp;Martine J. Jager","doi":"10.1016/j.aopr.2024.12.001","DOIUrl":"10.1016/j.aopr.2024.12.001","url":null,"abstract":"<div><h3>Background</h3><div>Targeted therapy is a promising approach to improve the treatment of tumors, including ocular malignancies. Current therapies, such as radiotherapy and surgery, often lead to serious damage to vision or to loss of the eye. New approaches have examined nanoparticles for use as targeted delivery vehicles for drugs. A newly-developed virus-like drug conjugate is a promising nanoparticle with a defined target: the novel virus-like particle-photosensitizer conjugate Belzupacap sarotalocan (Bel-sar, previous name AU-011).</div></div><div><h3>Main text</h3><div>In this review, we summarize the application of this novel light-activated virus-like particle conjugate in pre-clinical and clinical studies and discuss its potential to treat ocular malignancies, such as uveal melanoma and conjunctival melanoma. We furthermore discuss the combination with immunotherapy and its application on pigmented and non-pigmented tumors as well as its effect on macrophage polarization, which is important to achieve effective results in immunotherapy.</div></div><div><h3>Conclusions</h3><div>Belzupacap sarotalocan (Bel-sar) is a promising targeted drug carrier that enhances tumor-specific delivery and minimizes off-target effects. Its photodynamic therapy effectively treats pigmented and non-pigmented tumors while inducing immunogenic cell death through DAMP exposure, triggering local and systemic immune responses. Combining Bel-sar PDT with immunotherapy improves efficacy in preclinical models, warranting further clinical investigation.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"5 1","pages":"Pages 49-57"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143178233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Causal association between non-thyroidal autoimmune diseases and Graves' ophthalmopathy: A mendelian randomization study 非甲状腺自身免疫性疾病与Graves眼病的因果关系:一项孟德尔随机研究
Pub Date : 2025-02-01 DOI: 10.1016/j.aopr.2024.11.004
Lan Ma, Xue Jiang, Zhijia Hou, Dongmei Li

Purpose

This Mendelian randomization (MR) analysis study aimed to investigate the genetic causal relationship between non-thyroidal autoimmune diseases (ADs) and Graves' ophthalmopathy (GO).

Materials

Single nucleotide polymorphisms (SNPs) associated with inflammatory bowel disease (IBD), multiple sclerosis (MS), psoriasis vulgaris (PV), type 1 diabetes (T1D), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA) were obtained from the IEU Open genome-wide association studies (GWAS) database, GWAS data for GO were obtained from the FinnGen database. Bidirectional MR analysis was conducted using inverse variance weighted (IVW) method, weighted median (WM) method and MR-Egger test. Cochran's Q statistic was used to assess the heterogeneity between SNP estimates. MR-Egger regression was used to evaluate horizontal pleiotropy and MR pleiotropy residual sum and outlier (MR-PRESSO) test was used to detect the outliers.

Results

For non-thyroidal ADs, the forward MR results using the IVM method showed that T1D (OR ​= ​1.259, 95%CI 1.026–1.5465; P ​= ​0.028) and SLE (OR ​= ​1.807, 95%CI 1.229–2.655; P ​= ​0.003) were correlated with the risk of GO at the genetic level, while there was no evidence showing that IBD, MS, PV and RA were correlated with GO. In the reverse MR study, there was a significant increase in the risk of developing T1D in GO (OR ​= ​1.135, 95%CI 1.018–1.265; P ​= ​0.022), but pleiotropy and heterogeneity existed.

Conclusions

In the European population, there is strong genetic evidence that patients with T1D and SLE have a higher risk of developing GO, whereas the effect of GO on ADs is unclear.
目的本研究旨在探讨非甲状腺性自身免疫性疾病(ADs)与Graves眼病(GO)的遗传因果关系。材料:炎症性肠病(IBD)、多发性硬化症(MS)、寻常型牛皮癣(PV)、1型糖尿病(T1D)、系统性红斑狼疮(SLE)和类风湿性关节炎(RA)相关的单核苷酸多态性(snp)来自IEU Open全基因组关联研究(GWAS)数据库,GO的GWAS数据来自FinnGen数据库。双向MR分析采用逆方差加权法(IVW)、加权中位数法(WM)和MR- egger检验。Cochran’s Q统计量用于评估SNP估计值之间的异质性。水平多效性采用MR- egger回归评价,MR多效性残差和采用异常值检验(MR- presso)检测异常值。结果对于非甲状腺性ad,采用IVM方法的正向MR结果显示T1D (OR = 1.259, 95%CI 1.026 ~ 1.5465;P = 0.028)和系统性红斑狼疮(OR = 1.807, 95% ci 1.229 - -2.655;P = 0.003)在遗传水平上与GO风险相关,而IBD、MS、PV和RA与GO无相关性。在反向MR研究中,GO患者发生T1D的风险显著增加(OR = 1.135, 95%CI 1.018-1.265;P = 0.022),但存在多效性和异质性。结论在欧洲人群中,有强有力的遗传证据表明,T1D和SLE患者发生氧化石墨烯的风险更高,而氧化石墨烯对ad的影响尚不清楚。
{"title":"Causal association between non-thyroidal autoimmune diseases and Graves' ophthalmopathy: A mendelian randomization study","authors":"Lan Ma,&nbsp;Xue Jiang,&nbsp;Zhijia Hou,&nbsp;Dongmei Li","doi":"10.1016/j.aopr.2024.11.004","DOIUrl":"10.1016/j.aopr.2024.11.004","url":null,"abstract":"<div><h3>Purpose</h3><div>This Mendelian randomization (MR) analysis study aimed to investigate the genetic causal relationship between non-thyroidal autoimmune diseases (ADs) and Graves' ophthalmopathy (GO).</div></div><div><h3>Materials</h3><div>Single nucleotide polymorphisms (SNPs) associated with inflammatory bowel disease (IBD), multiple sclerosis (MS), psoriasis vulgaris (PV), type 1 diabetes (T1D), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA) were obtained from the IEU Open genome-wide association studies (GWAS) database, GWAS data for GO were obtained from the FinnGen database. Bidirectional MR analysis was conducted using inverse variance weighted (IVW) method, weighted median (WM) method and MR-Egger test. Cochran's Q statistic was used to assess the heterogeneity between SNP estimates. MR-Egger regression was used to evaluate horizontal pleiotropy and MR pleiotropy residual sum and outlier (MR-PRESSO) test was used to detect the outliers.</div></div><div><h3>Results</h3><div>For non-thyroidal ADs, the forward MR results using the IVM method showed that T1D (OR ​= ​1.259, 95%CI 1.026–1.5465; <em>P</em> ​= ​0.028) and SLE (OR ​= ​1.807, 95%CI 1.229–2.655; <em>P</em> ​= ​0.003) were correlated with the risk of GO at the genetic level, while there was no evidence showing that IBD, MS, PV and RA were correlated with GO. In the reverse MR study, there was a significant increase in the risk of developing T1D in GO (OR ​= ​1.135, 95%CI 1.018–1.265; <em>P</em> ​= ​0.022), but pleiotropy and heterogeneity existed.</div></div><div><h3>Conclusions</h3><div>In the European population, there is strong genetic evidence that patients with T1D and SLE have a higher risk of developing GO, whereas the effect of GO on ADs is unclear.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"5 1","pages":"Pages 66-72"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143379455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An anatomical study of the medial wall, lateral wall, roof, and floor of the Filipino orbit 菲律宾人眼眶内壁、外侧壁、顶和底的解剖学研究
Pub Date : 2025-02-01 DOI: 10.1016/j.aopr.2024.10.002
Lorenzo Angelo R. Santos, Reynaldo M. Javate
{"title":"An anatomical study of the medial wall, lateral wall, roof, and floor of the Filipino orbit","authors":"Lorenzo Angelo R. Santos,&nbsp;Reynaldo M. Javate","doi":"10.1016/j.aopr.2024.10.002","DOIUrl":"10.1016/j.aopr.2024.10.002","url":null,"abstract":"","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"5 1","pages":"Pages 73-77"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143387277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world assessment of second-generation trabecular micro-bypass stents in open-angle glaucoma patients 第二代小梁微搭桥支架治疗开角型青光眼的临床评价。
Pub Date : 2025-02-01 DOI: 10.1016/j.aopr.2024.09.002
Vishal Vohra , Indira Madgula , Harshika Chawla

Background

To assess the safety and efficacy of iStent inject placement in individuals with glaucoma with open angles in real world clinical settings.

Methods

A review was conducted on the medical records of individuals who received iStent inject implants starting from March 2018. The analysis focused on reductions in intraocular pressure (IOP) and glaucoma medication usage. Safety assessments encompassed intraoperative and postoperative issues, additional surgeries, and improvements in best-corrected visual acuity (BCVA).

Results

Analysis of 55 eyes of 48 patients that underwent iStent implantation revealed a mean age of 77 years (range: 51–97). The initial average intraocular pressure (IOP) in these eyes was 20.2 ​± ​6.4 ​mm Hg. Following surgery, IOP decreased by ​≥ ​20% compared to preoperative levels in 21 eyes (43.8%) over the 12-month follow-up period. Notably, there was a significant reduction in medication usage by the 12-month mark (P ​< ​0.0042). Among the evaluated eyes, 9 exhibited a response to steroids, 3 had stents that were improperly positioned, 5 had stents that were over implanted, and 1 eye experienced an episode of iris prolapse.

Conclusions

The findings from the 12-month follow-up of iStent inject implants in standard clinical settings demonstrate a notable decrease in both intraocular pressure (IOP) and medication usage in eyes with concurrent open-angle glaucoma.
背景:在现实世界的临床环境中,评估iStent注射置入治疗开角青光眼患者的安全性和有效性。方法:对2018年3月以来接受iStent注射种植体治疗的患者病历进行回顾性分析。分析的重点是眼压(IOP)和青光眼药物使用的降低。安全性评估包括术中和术后问题、额外手术和最佳矫正视力(BCVA)的改善。结果:48例55眼植入术患者,平均年龄77岁(51 ~ 97岁)。这些眼睛的初始平均眼压(IOP)为20.2±6.4 mm Hg。手术后,在12个月的随访期间,21只眼睛(43.8%)的IOP与术前水平相比下降了≥20%。值得注意的是,在12个月的时间里,药物使用显著减少(P结论:在标准临床环境下,iStent注射植入物12个月的随访结果表明,并发开角型青光眼的眼内压(IOP)和药物使用均显著降低。
{"title":"Real-world assessment of second-generation trabecular micro-bypass stents in open-angle glaucoma patients","authors":"Vishal Vohra ,&nbsp;Indira Madgula ,&nbsp;Harshika Chawla","doi":"10.1016/j.aopr.2024.09.002","DOIUrl":"10.1016/j.aopr.2024.09.002","url":null,"abstract":"<div><h3>Background</h3><div>To assess the safety and efficacy of iStent inject placement in individuals with glaucoma with open angles in real world clinical settings.</div></div><div><h3>Methods</h3><div>A review was conducted on the medical records of individuals who received iStent inject implants starting from March 2018. The analysis focused on reductions in intraocular pressure (IOP) and glaucoma medication usage. Safety assessments encompassed intraoperative and postoperative issues, additional surgeries, and improvements in best-corrected visual acuity (BCVA).</div></div><div><h3>Results</h3><div>Analysis of 55 eyes of 48 patients that underwent iStent implantation revealed a mean age of 77 years (range: 51–97). The initial average intraocular pressure (IOP) in these eyes was 20.2 ​± ​6.4 ​mm Hg. Following surgery, IOP decreased by ​≥ ​20% compared to preoperative levels in 21 eyes (43.8%) over the 12-month follow-up period. Notably, there was a significant reduction in medication usage by the 12-month mark (<em>P</em> ​&lt; ​0.0042). Among the evaluated eyes, 9 exhibited a response to steroids, 3 had stents that were improperly positioned, 5 had stents that were over implanted, and 1 eye experienced an episode of iris prolapse.</div></div><div><h3>Conclusions</h3><div>The findings from the 12-month follow-up of iStent inject implants in standard clinical settings demonstrate a notable decrease in both intraocular pressure (IOP) and medication usage in eyes with concurrent open-angle glaucoma.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"5 1","pages":"Pages 16-21"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11787460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Closing eyes with artificial tears: A simple and effective strategy to combat screen-related asthenopia and dry eye symptoms 用人工泪液闭眼:应对屏幕相关性远视和干眼症状的简单有效策略
Pub Date : 2025-02-01 DOI: 10.1016/j.aopr.2024.07.001
Ning Wang , Jinjin Min , Xiaojing Fan , Xiuming Jin

Background

The widespread use of various video display terminals (VDTs) always had a detrimental impact on ocular health. Prolonged use of smartphones has been one of the leading causes of dry eye (DE) and asthenopia. Therefore, the purpose of this study is to find a simple and effective strategy to combat screen-related DE and asthenopia.

Methods

A group of healthy participants aged 18 and above were randomly assigned to three groups and tasked with a 2 h smartphone reading task. After 1 ​h of usage, each group adopted different methods of rest: no rest (Group A), a 10 min eye-closed rest (Group B), or a 10 min eye-closed joint artificial tears rest (Group C). Ophthalmological examinations and questionnaires were administered to all participants before and after the 2 h reading task.

Results

90 qualified volunteers, including 29 males and 61 females, were randomly assigned to three groups. Group A demonstrated a significant increase in the severity of DE and asthenopia as evidenced by all the evaluated indices. On the other hand, Group C did not exhibit any notable change in DE and asthenopia symptoms, with an improvement in corneal fluorescein staining (CFS) results (P ​> ​0.05) when compared to the pre-reading values. Group B showed a significant increase in ocular surface disease index (OSDI) (P ​≤ ​0.05) and a decrease in critical flicker frequency (CFF) (P ​≤ ​0.05).

Conclusions

Close-eye rest with artificial tears may be a convenient and effective prevention strategy for screen-related DE and asthenopia.
各种视频显示终端(vdt)的广泛使用一直对眼睛健康造成不利影响。长时间使用智能手机是导致干眼症和弱视的主要原因之一。因此,本研究的目的是寻找一种简单有效的策略来对抗与屏幕相关的DE和视疲劳。方法将18岁及以上的健康受试者随机分为三组,分别进行2小时的智能手机阅读任务。使用1 h后,各组采用不同的休息方式:不休息(A组)、闭眼休息10 min (B组)、闭眼关节人工泪液休息10 min (C组)。在2 h阅读任务前后对所有参与者进行眼科检查和问卷调查。结果90名符合条件的志愿者,包括29名男性和61名女性,被随机分为三组。所有评价指标均显示A组DE和视疲劳的严重程度明显增加。另一方面,C组角膜荧光素染色(CFS)结果有所改善,但DE和视弱症状没有明显变化(P >;0.05),与预读值相比。B组患者眼表疾病指数(OSDI)显著升高(P≤0.05),临界闪烁频率(CFF)显著降低(P≤0.05)。结论人工泪液闭眼休息可能是一种方便有效的预防屏幕相关性DE和视弱视的方法。
{"title":"Closing eyes with artificial tears: A simple and effective strategy to combat screen-related asthenopia and dry eye symptoms","authors":"Ning Wang ,&nbsp;Jinjin Min ,&nbsp;Xiaojing Fan ,&nbsp;Xiuming Jin","doi":"10.1016/j.aopr.2024.07.001","DOIUrl":"10.1016/j.aopr.2024.07.001","url":null,"abstract":"<div><h3>Background</h3><div>The widespread use of various video display terminals (VDTs) always had a detrimental impact on ocular health. Prolonged use of smartphones has been one of the leading causes of dry eye (DE) and asthenopia. Therefore, the purpose of this study is to find a simple and effective strategy to combat screen-related DE and asthenopia.</div></div><div><h3>Methods</h3><div>A group of healthy participants aged 18 and above were randomly assigned to three groups and tasked with a 2 h smartphone reading task. After 1 ​h of usage, each group adopted different methods of rest: no rest (Group A), a 10 min eye-closed rest (Group B), or a 10 min eye-closed joint artificial tears rest (Group C). Ophthalmological examinations and questionnaires were administered to all participants before and after the 2 h reading task.</div></div><div><h3>Results</h3><div>90 qualified volunteers, including 29 males and 61 females, were randomly assigned to three groups. Group A demonstrated a significant increase in the severity of DE and asthenopia as evidenced by all the evaluated indices. On the other hand, Group C did not exhibit any notable change in DE and asthenopia symptoms, with an improvement in corneal fluorescein staining (CFS) results (<em>P</em> ​&gt; ​0.05) when compared to the pre-reading values. Group B showed a significant increase in ocular surface disease index (OSDI) (<em>P</em> ​≤ ​0.05) and a decrease in critical flicker frequency (CFF) (<em>P</em> ​≤ ​0.05).</div></div><div><h3>Conclusions</h3><div>Close-eye rest with artificial tears may be a convenient and effective prevention strategy for screen-related DE and asthenopia.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"5 1","pages":"Pages 58-65"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141692128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decline in US–China science: Can ophthalmology remain collaborative? 中美科学的衰落:眼科能保持合作吗?
Pub Date : 2025-02-01 DOI: 10.1016/j.aopr.2024.11.002
Kevin Y. Huang , Parth A. Patel , Austin Huang, Allen C. Ho, Jost B. Jonas, Xiaodong Sun, Youxin Chen, Yingfeng Zheng, Yih-Chung Tham, Christina Y. Weng, Tien Yin Wong
{"title":"Decline in US–China science: Can ophthalmology remain collaborative?","authors":"Kevin Y. Huang ,&nbsp;Parth A. Patel ,&nbsp;Austin Huang,&nbsp;Allen C. Ho,&nbsp;Jost B. Jonas,&nbsp;Xiaodong Sun,&nbsp;Youxin Chen,&nbsp;Yingfeng Zheng,&nbsp;Yih-Chung Tham,&nbsp;Christina Y. Weng,&nbsp;Tien Yin Wong","doi":"10.1016/j.aopr.2024.11.002","DOIUrl":"10.1016/j.aopr.2024.11.002","url":null,"abstract":"","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"5 1","pages":"Pages 13-15"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11729649/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel RP1 truncating mutation that causes autosomal dominant retinitis pigmentosa (ADRP) 一种新的RP1截断突变导致常染色体显性视网膜色素变性(ADRP)
Pub Date : 2025-02-01 DOI: 10.1016/j.aopr.2024.08.005
Wei Wu , Ying Zhang , Jingjie Xu , Hua Jiang , Xiangjun Chen

Background

Retinitis pigmentosa (RP) is a genetically and clinically heterogeneous group of hereditary degenerative disorders affecting approximately one in every 4000 people worldwide. Abnormalities in the retina's photoreceptors can cause night blindness or even complete vision loss. Retinitis Pigmentosa 1 (RP1), also known as the oxygen-regulated protein-1, is a microtubule-associated protein (MAP) that organizes the outer segment of the photoreceptor. Besides, mutations in the RP1 gene are associated with dominant or recessive form of RP. This study aims to identify the potential pathogenic genes in Chinese RP patients and to elucidate the association relationship between the mutant gene and the phenotypes.

Methods

Multiple ophthalmic examinations, whole-exome sequencing, sanger sequencing, and in silico analysis were performed to evaluate the clinical features and pathogenic genes in a five-generation Chinese family diagnosed with RP.

Results

Our findings revealed a novel truncating mutation c.2015_2018del p. (Lys672Argfs∗9) in RP1 that may result in the translation of a protein with deleterious effects on photoreceptors. Therefore, resulting in autosomal dominant retinitis pigmentosa (ADRP).

Conclusions

This study broaden the range of genetic mutations associated with RP1 in ADRP and make a valuable contribution to the ongoing endeavors aimed at characterizing the molecular aspects of Chinese ADRP. Future studies would pay more attention in determining the characterization of the mutantations in RP1 gene and the relationship between genotype and phenotype in RP patients.
背景:色素性视网膜炎(RP)是一种遗传和临床异质性的遗传性退行性疾病,全世界大约每4000人中就有1人受到影响。视网膜感光器的异常会导致夜盲症甚至完全失明。视网膜色素变性1 (RP1)也被称为氧调节蛋白1,是一种组织光感受器外段的微管相关蛋白(MAP)。此外,RP1基因的突变与显性或隐性形式的RP有关。本研究旨在鉴定中国RP患者的潜在致病基因,并阐明突变基因与表型之间的关联。方法采用多项眼科检查、全外显子组测序、sanger测序和计算机分析等方法,对中国一个五代RP家族的临床特征和致病基因进行分析。我们的研究结果揭示了RP1中一个新的截断突变c.2015_2018del p. (Lys672Argfs * 9),该突变可能导致一种对光感受器有有害影响的蛋白质的翻译。因此,导致常染色体显性视网膜色素变性(ADRP)。结论本研究拓宽了ADRP中与RP1相关的基因突变范围,为进一步研究中国ADRP的分子特征做出了重要贡献。未来的研究将更多地关注RP患者RP1基因突变的特征以及基因型与表型的关系。
{"title":"A novel RP1 truncating mutation that causes autosomal dominant retinitis pigmentosa (ADRP)","authors":"Wei Wu ,&nbsp;Ying Zhang ,&nbsp;Jingjie Xu ,&nbsp;Hua Jiang ,&nbsp;Xiangjun Chen","doi":"10.1016/j.aopr.2024.08.005","DOIUrl":"10.1016/j.aopr.2024.08.005","url":null,"abstract":"<div><h3>Background</h3><div>Retinitis pigmentosa (RP) is a genetically and clinically heterogeneous group of hereditary degenerative disorders affecting approximately one in every 4000 people worldwide. Abnormalities in the retina's photoreceptors can cause night blindness or even complete vision loss. Retinitis Pigmentosa 1 (RP1), also known as the oxygen-regulated protein-1, is a microtubule-associated protein (MAP) that organizes the outer segment of the photoreceptor. Besides, mutations in the <em>RP1</em> gene are associated with dominant or recessive form of RP. This study aims to identify the potential pathogenic genes in Chinese RP patients and to elucidate the association relationship between the mutant gene and the phenotypes.</div></div><div><h3>Methods</h3><div>Multiple ophthalmic examinations, whole-exome sequencing, sanger sequencing, and <em>in silico</em> analysis were performed to evaluate the clinical features and pathogenic genes in a five-generation Chinese family diagnosed with RP.</div></div><div><h3>Results</h3><div>Our findings revealed a novel truncating mutation c.2015_2018del p. (Lys672Argfs∗9) in <em>RP1</em> that may result in the translation of a protein with deleterious effects on photoreceptors. Therefore, resulting in autosomal dominant retinitis pigmentosa (ADRP).</div></div><div><h3>Conclusions</h3><div>This study broaden the range of genetic mutations associated with <em>RP1</em> in ADRP and make a valuable contribution to the ongoing endeavors aimed at characterizing the molecular aspects of Chinese ADRP. Future studies would pay more attention in determining the characterization of the mutantations in <em>RP1</em> gene and the relationship between genotype and phenotype in RP patients.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"5 1","pages":"Pages 41-48"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143178240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gut-eye axis Gut-eye轴
Pub Date : 2025-01-27 DOI: 10.1016/j.aopr.2025.01.003
Weixin Zheng , Mingzhi Su , Ningxi Hong , Panpan Ye

Background

The gut microbiome, colonizing the human gastrointestinal tract, is increasingly recognized for its symbiotic relationship with the immune system in maintaining overall host health. This emerging understanding raises intriguing questions about potential connections between the gut microbiome and anatomically distant organs, such as the eye, possibly mediated through immune pathways.

Main text

This review synthesizes contemporary research on ocular diseases with the framework of the burgeoning "gut-eye axis" concept. Investigations spanning from the ocular surface to the fundus suggest correlations between the gut microbiome and various ocular disorders. By elucidating the putative pathogenic mechanisms underlying these ocular conditions, we offer novel perspectives to inform future diagnostic and therapeutic interventions in ophthalmology.

Conclusions

By presenting a critical analysis of current knowledge regarding the role of gastrointestinal microbiota in ocular health, this review shed light on the complex interplay between gut dysbiosis and eye disorders. Our work endeavors to catalyze interdisciplinary research and foster innovative clinical applications, thereby bridging the gap between the gut microbiota and the ocular well-being.
肠道菌群,定植于人类胃肠道,在维持宿主整体健康方面与免疫系统的共生关系日益得到认可。这种新兴的理解提出了一个有趣的问题,即肠道微生物群与解剖学上遥远的器官(如眼睛)之间的潜在联系,可能是通过免疫途径介导的。本文以新兴的“肠眼轴”概念为框架,对当代眼科疾病的研究进行了综述。从眼表到眼底的研究表明肠道微生物群与各种眼部疾病之间存在相关性。通过阐明这些眼部疾病的潜在致病机制,我们为眼科未来的诊断和治疗干预提供了新的视角。结论:通过对目前关于胃肠道微生物群在眼部健康中的作用的知识进行批判性分析,本综述揭示了肠道生态失调和眼部疾病之间复杂的相互作用。我们的工作致力于促进跨学科研究和促进创新的临床应用,从而弥合肠道微生物群和眼部健康之间的差距。
{"title":"Gut-eye axis","authors":"Weixin Zheng ,&nbsp;Mingzhi Su ,&nbsp;Ningxi Hong ,&nbsp;Panpan Ye","doi":"10.1016/j.aopr.2025.01.003","DOIUrl":"10.1016/j.aopr.2025.01.003","url":null,"abstract":"<div><h3>Background</h3><div>The gut microbiome, colonizing the human gastrointestinal tract, is increasingly recognized for its symbiotic relationship with the immune system in maintaining overall host health. This emerging understanding raises intriguing questions about potential connections between the gut microbiome and anatomically distant organs, such as the eye, possibly mediated through immune pathways.</div></div><div><h3>Main text</h3><div>This review synthesizes contemporary research on ocular diseases with the framework of the burgeoning \"gut-eye axis\" concept. Investigations spanning from the ocular surface to the fundus suggest correlations between the gut microbiome and various ocular disorders. By elucidating the putative pathogenic mechanisms underlying these ocular conditions, we offer novel perspectives to inform future diagnostic and therapeutic interventions in ophthalmology.</div></div><div><h3>Conclusions</h3><div>By presenting a critical analysis of current knowledge regarding the role of gastrointestinal microbiota in ocular health, this review shed light on the complex interplay between gut dysbiosis and eye disorders. Our work endeavors to catalyze interdisciplinary research and foster innovative clinical applications, thereby bridging the gap between the gut microbiota and the ocular well-being.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"5 3","pages":"Pages 165-174"},"PeriodicalIF":0.0,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144254193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the accuracy of advanced language learning models in ophthalmology: A comparative study of ChatGPT-4o and Meta AI's Llama 3.1 评估眼科高级语言学习模型的准确性:chatgpt - 40与Meta AI的Llama 3.1的比较研究
Pub Date : 2025-01-06 DOI: 10.1016/j.aopr.2025.01.002
Trevor Lin , Ryan T. Lin , Rahul Mhaskar , Curtis E. Margo
{"title":"Evaluating the accuracy of advanced language learning models in ophthalmology: A comparative study of ChatGPT-4o and Meta AI's Llama 3.1","authors":"Trevor Lin ,&nbsp;Ryan T. Lin ,&nbsp;Rahul Mhaskar ,&nbsp;Curtis E. Margo","doi":"10.1016/j.aopr.2025.01.002","DOIUrl":"10.1016/j.aopr.2025.01.002","url":null,"abstract":"","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"5 2","pages":"Pages 95-99"},"PeriodicalIF":0.0,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143629154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Advances in ophthalmology practice and research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1